Home > Insider Trading > Filing (0001628280-19-010785)

Filing Details

Accession Number:: 0001628280-19-010785
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-14 19:13:23
Reporting Period:: 2019-08-12

Accepted Time:: 2019-08-14 19:13:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752968	Helmy Eltoukhy	505 Penobscot Drive Redwood City CA 94063	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-08-12	38,109	$4.18	4,025,074	No	4	M	Direct
Common Stock	Disposition	2019-08-12	5,309	$96.48	4,019,765	No	4	S	Direct
Common Stock	Disposition	2019-08-12	17,105	$97.61	4,002,660	No	4	S	Direct
Common Stock	Disposition	2019-08-12	45,010	$98.64	3,957,650	No	4	S	Direct
Common Stock	Disposition	2019-08-12	51,254	$99.58	3,906,396	No	4	S	Direct
Common Stock	Disposition	2019-08-12	273	$100.29	3,906,123	No	4	S	Direct
Common Stock	Disposition	2019-08-12	140	$101.19	3,905,983	No	4	S	Direct
Common Stock	Acquisiton	2019-08-13	98,307	$4.18	4,004,290	No	4	M	Direct
Common Stock	Disposition	2019-08-13	2,400	$96.79	4,001,890	No	4	S	Direct
Common Stock	Disposition	2019-08-13	11,813	$97.83	3,990,077	No	4	S	Direct
Common Stock	Disposition	2019-08-13	44,446	$98.96	3,945,631	No	4	S	Direct
Common Stock	Disposition	2019-08-13	158,529	$99.83	3,787,102	No	4	S	Direct
Common Stock	Disposition	2019-08-13	89,416	$100.75	3,697,686	No	4	S	Direct
Common Stock	Disposition	2019-08-13	606	$101.30	3,697,080	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2019-08-12	38,109	$0.00	38,109	$4.18
Common Stock	STOCK OPTION (RIGHT TO BUY)	Disposition	2019-08-13	98,307	$0.00	98,307	$4.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,135,718		2022-07-13	No	4	M	Direct
1,037,411		2022-07-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	119,550	Indirect	Shares held by Helmy A. Eltoukhy Revocable Trust
Common Stock	664,020	Indirect	Shares held by Eltoukhy Investments, L.P.

Footnotes

These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.02 to $97.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.05 to $98.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.05 to $99.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.05 to $100.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.05 to $101.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.16 to $101.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.24 to $97.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.26 to $100.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.26 to $101.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.26 to $101.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.